Table 1.
Personal and Clinical Characteristics of Participants (N = 836)
| Aged <60 years*, n = 610, n(%) or mean(SD) | Aged ≥60 years*, n = 226, n(%) or mean (SD) | p value† | |
|---|---|---|---|
| Age now (years) | 57.7 (11.3), range 23–89 | 72.9 (6.0) range 61–90 | <0.001 |
| Age at diagnosis (years) | 46.3 (9.8), range 18–59 | 66.9 (5.2) range 60–82 | N/A |
| Years since diagnosis | 11.4 (9.5), range 0.5–43 | 5.9 (4.7) range 0.5–29 | <0.001 |
| Female gender | 474 (78) | 127 (56) | <0.001 |
| Ethnicity | 0.24 | ||
| White | 566 (93) | 217 (96) | |
| Maori | 29 (5) | 6 (3) | |
| Other | 15 (2) | 3 (1) | |
| Education | 0.001 | ||
| High school or less | 217 (36) | 97 (44) | |
| University | 290 (48) | 101 (45) | |
| Postgraduate degree | 99 (16) | 25 (11) | |
| Household income (at time of diagnosis) | n = 582 | n = 217 | <0.001 |
| Less than US$ 30,999 | 208 (36) | 122 (56) | |
| US$ 31,000–61,999 | 234 (40) | 70 (32) | |
| US$ 62,000–77,999 | 66 (11) | 14 (6) | |
| More than US$ 78,000 | 74 (12) | 11 (5) | |
| Type of cancer | <0.001 | ||
| Breast | 282 (46) | 75 (33) | |
| Colon, rectum | 82 (13) | 53 (23) | |
| Leukemia/lymphoma | 59 (10) | 15 (7) | |
| Ovary/cervix | 41 (7) | 9 (4) | |
| Prostate | 21 (3) | 28 (12) | |
| Other (less than 5% prevalence) | 125 (21) | 46 (20) | |
| Surgical treatment only | 118 (21), n = 567 | 62 (31), n = 202 | 0.01 |
| Chemo/radiation therapy | 449 (78), n = 567 | 138 (68), n = 202 | 0.03 |
*Age at time of cancer diagnosis; †t-test for means, chi-square for proportions
Groups may not total exactly 100% because percentages are rounded